Viewing Study NCT01019161


Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2025-12-30 @ 11:32 AM
Study NCT ID: NCT01019161
Status: COMPLETED
Last Update Posted: 2010-10-20
First Post: 2009-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module